News

Queenslanders could have skin cancer diagnosed earlier using world-first 3D scanning technology with the launch of the Australian Cancer Research Foundation Australian Centre of Excellence in Melanoma Imaging and Diagnosis.

A study involving 15,000 Australians which aims to develop a next-generation, standardised diagnosis for melanoma is one of 30 clinical trials and cohort studies to be funded through the National Health and Medical Research Council’s $74 million investment to find better ways to prevent, detect and treat disease.

The ACRF Australian Centre of Excellence in Melanoma Imaging and Diagnosis has been named a part of a Monash University led national project to ensure research data remains both secure and FAIR (Findable, Accessible, Interoperable and Reusable) thanks to more than $950k from the Australian Research Data Commons (ARDC) and over $1.3m from other partners.

Artificial intelligence (AI) improved skin cancer diagnostic accuracy when used in collaboration with human clinical checks, an international study including University of Queensland researchers has found.

Melanoma is the most deadly form of skin cancer and currently costs taxpayers more than $100 million annually.

Melanoma affects 1 in 17 Australians, and other skin cancers 2 in 3 Australians, but setting up a formal screening program like we have for breast, cervical and bowel cancer is trickier than you might think.

A $10 million grant will revolutionise the early detection of melanoma with the installation of 15 3D whole body imaging machines across Queensland, New South Wales and Victoria.